IMMUNITYBIO INC's ticker is IBRX and the CUSIP is 45256X103. A total of 130 filers reported holding IMMUNITYBIO INC in Q3 2022. The put-call ratio across all filers is 1.40 and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $18,270,643 | -30.8% | 10,811,031 | +13.8% | 0.00% | 0.0% |
| Q2 2023 | $26,406,292 | +108.3% | 9,498,666 | +36.4% | 0.00% | – |
| Q1 2023 | $12,677,245 | -64.4% | 6,965,519 | -0.8% | 0.00% | -100.0% |
| Q4 2022 | $35,592,080 | +15.2% | 7,020,134 | +12.9% | 0.00% | 0.0% |
| Q3 2022 | $30,901,000 | +40.6% | 6,217,199 | +5.2% | 0.00% | 0.0% |
| Q2 2022 | $21,975,000 | -23.4% | 5,907,649 | +15.5% | 0.00% | 0.0% |
| Q1 2022 | $28,683,000 | -11.7% | 5,112,873 | -4.3% | 0.00% | 0.0% |
| Q4 2021 | $32,479,000 | -39.9% | 5,341,818 | -3.8% | 0.00% | -50.0% |
| Q3 2021 | $54,072,000 | -28.2% | 5,551,568 | +5.3% | 0.00% | 0.0% |
| Q2 2021 | $75,300,000 | -10.7% | 5,273,157 | +48.4% | 0.00% | 0.0% |
| Q1 2021 | $84,365,000 | – | 3,553,665 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Winning Points Advisors, LLC | 236,956 | $879,000 | 0.97% |
| HARBOURVEST PARTNERS LLC | 335,709 | $1,249,000 | 0.41% |
| ALLEN HOLDING INC /NY | 687,571 | $2,558,000 | 0.37% |
| MERIDIAN INVESTMENT COUNSEL INC. | 96,433 | $359,000 | 0.15% |
| SHEETS SMITH WEALTH MANAGEMENT | 207,926 | $773,000 | 0.13% |
| Corton Capital Inc. | 29,032 | $108,000 | 0.10% |
| Clearwater Capital Advisors, LLC | 185,311 | $689,000 | 0.09% |
| Delphia (USA) Inc. | 31,709 | $118,000 | 0.08% |
| Virtus ETF Advisers LLC | 34,799 | $129,000 | 0.05% |
| GSA CAPITAL PARTNERS LLP | 84,884 | $316,000 | 0.05% |